contact about AusPharmList.net.au AusPharm.net.au AusPharmacist.net.au Priceline Pharmacy
www.auspharm.net.au
www.auspharm.net.au

 
Monday 25 June 2007 premium Signifies 'premium' content
 

Lancet: Clinical update: new treatments for hot flushes
FDA: Pregabalin (Lyrica) approved for treating fibromyalgia
New England Journal of Medicine: Estrogen Therapy and Coronary-Artery Calcification
American Journal of Clinical Nutrition: Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density . More.... premium

AusPharm Research Roundup is a weekly column collated by Debbie Rigby that is designed to bring AusPharmers a summary of selected research papers published during the preceding week or two.

 
 

More on Roche vs the NDPSC

"Roche disagrees with the NDPSC's decision to remove the ability for Xenic*l to brand advertise at its February 2007 meeting as it believes that it is against the interests of public health.

Roche is pursuing its right to challenge the decision via the appropriate channels. The case will be heard in Sydney in the Federal Court of Australia at the end of July and Roche believes that further debate and discussion should be left to the court. Roche is taking the action against the Committee through the individual members as it is the only way for us to challenge the NDPSC decision."
More....
 
 

PayPal giving you grief?

As an end of financial year 'special' we are offering AusPharm premium members the opportunity to renew their subscriptions early and save $33 off the regular price. If you renew between now and June 30 we'll extend your subscription by 12 months for just $99 (inc gst). The normal price is $132. For most people this would also mean that the cost of your subscription will be tax deductible in the current financial year.

To renew your subscription now, click on the PayPal logo above, log in to your AusPharm member page and follow the prompts.

AusPharm has received one or two emails from members saying that PayPal had rejected their credit card details. We also know that the PayPal website has been down occasionally during the last week. For whatever reason, if PayPal defeats you, email us and we'll send you an account that offers other payment options.
 
 
  1. (UK) Parliamentarians don't support Reclassification of Pseudoephedrine....... Bill Arnold 23/06/2007
  2. Do you use Packman with LOTS?....... John Sobkowiak 22/06/2007
  3. FERRO LIQUID CMI?....... Peter Ryan 22/06/2007
  4. Re: Online claiming for PBS technical difficulties fixed....... Amanda Galbraith 22/06/2007
  5. Ural....... Vicki Dyson 22/06/2007
  6. xeloda....... anderson leong 23/06/2007
  7. Re: Secure emails to Doctors....... Andrew Roberts 23/06/2007
  8. Re: Riddle me this........... Andrew Roberts 23/06/2007
  9. Re: '01' code to go....... irwin lowe 22/06/2007
  10. Re: Pearl: Wondermycin tds mnn....... Andrew Roberts 23/06/2007
  11. Re: Inappropriate(?) S3 supplies by others........ Peter Crothers 22/06/2007
  12. Re: Contraception....... Bruce Moffat 22/06/2007
  13. [student] : Re: Privacy....... Ben Wishaw 22/06/2007
  14. Re: Privacy....... Ian Bodycote 22/06/2007
  15. Re: Privacy....... Harriet Wright 22/06/2007
  16. Re: Privacy....... Geoff Timbs 22/06/2007
  17. Re: Medicare Nos. & RMMR....... Penny Kraemer 22/06/2007
  18. Re: Medicare Nos. & RMMR....... Damien Louttit 22/06/2007
  19. Re: Medicare Nos. & RMMR....... Edgar SMALL 22/06/2007
  20. Re: Streamlined authorities....... Geoff Timbs 22/06/2007
  21. Re: 200 scripts a day then get another pharmacist....... Peter Bayly 22/06/2007
  22. Re: 200 scripts a day then get another pharmacist....... Ron Batagol 24/06/2007
  23. Re: PBS online rejection codes....... Ian Bodycote 22/06/2007
 
 

Crikey! Colesworth in the wholesaler equation?

Last Fridays' Crikey ran an interesting story suggesting that the entry of private equity into wholesaler ownership might offer Colesworth a way into pharmacy. The reasoning goes like this. More....
 
 
  1. Assets play proves a bitter pill for Sigma as Symbion board swallows rival bid -- The Age 25/6/2007
  2. Naltrexone trial proposed in ACT -- ABC news 24/6/2007
  3. Hirst cabinet sets auction record -- BBC news 24/6/2007
  4. It's a brand new game -- The Age 24/6/2007
  5. Prescription drugs to be new road toll aim -- The Age 24/6/2007
  6. Chemist scheme rewarded for drug fight -- The Australian 23/6/2007
  7. Scheme praised over pseudo runners halt -- The Age 23/6/2007
  8. Diabetes drug fails to shake fears -- The Australian 23/6/2007
  9. Warning on drugs to cut post-surgical heart attacks -- The Australian 23/6/2007
  10. $4m shot in the arm for alternatives -- The Australian 23/6/2007
  11. Pharmacists prescribe a dose of relaxation -- Bay Post 22/6/2007
  12. 'Insulin pill' hope for diabetes -- BBC news 23/6/2007
  13. How to deal with the angry customer -- The Age 22/6/2007
  14. New European Guidelines on Treatment of Hypertension -- Medscape 22/6/2007
  15. Doctors change mind on HRT -- The Age 22/6/2007
  16. ASA supports Symbion's decision on Sigma's late bid -- The Age 22/6/2007
  17. Natural insulin hopes -- Herald Sun 22/6/2007
 
 

Project STOP wins national award

Project Stop, the innovative tool developed by the Pharmacy Guild of Australia to combat the manufacture of illegal drugs was honoured at the National Drug & Alcohol Awards in Sydney last week. It won the 'Excellence in Law Enforcement' award, which recognises a program, policy or resource that makes a significant contribution to reducing harmful alcohol or drug use. More....
 
 
  1. FDA approves 'Computerised Medication Box' for U.S. Market -- National electronic Library for Medicines 23/6/2007
  2. Postmenopausal Hormone Therapy and Coronary Disease -- Newswise 22/6/2007
 

Advertisers
and Sponsors


Pfizer

Sandoz - A healthy decision

NuSystems

AusPharm.net.au Job of the Week

Pharmaceutical Defence Limited

PSA - Memebership

Pharmacy Guild of Australia

Johnson & Johnson

NPS RADAR

WebsterCare

Raven's Pharmacy Services

Accu-Chek

Allied Health - Pharmacy Recruitment

jobs4careers

Cropper Parkhill

PCCA

JR Pharmacy Services

Australian College of Pharmacy Practice & Management

Click here to advertise here

PostScript Magazine

Australian Association of Consultant Pharmacy

practice4sale

pharm(e)footy


  

Project STOP wins national award

 
Project Stop, the innovative tool developed by the Pharmacy Guild of Australia to combat the manufacture of illegal drugs was honoured at the National Drug & Alcohol Awards in Sydney last week. It won the 'Excellence in Law Enforcement' award, which recognises a program, policy or resource that makes a significant contribution to reducing harmful alcohol or drug use.

Nominated by The Attorney General's Department, the award marks an important step in the introduction of Project STOP to pharmacies across Australia, after enjoying considerable success in Queensland pharmacies since October 2005. Since its inception in Queensland, Project STOP has contributed to a decrease in the number of clandestine drug laboratories and has assisted in more than 30 arrests.

"The diversion of pseudoephedrine for illegal manufacture into methamphetamines is a global problem," Kos Sclavos, National President of the Pharmacy Guild of Australia said.

"The national roll-out of Project STOP will help community pharmacy and law enforcement fight the misuse of cold and flu medications across Australia and maintain access to these effective medicines for legitimate consumers. The willingness of community pharmacists to utilise innovative technologies reflects their commitment to the principles of quality use of medicines, and their dedication to achieving the best health outcomes for the Australian community."

Post a comment to AusPharmList.

 

  

More on Roche vs the NDPSC

 
"Roche disagrees with the NDPSC's decision to remove the ability for Xenic*l to brand advertise at its February 2007 meeting as it believes that it is against the interests of public health.

Roche is pursuing its right to challenge the decision via the appropriate channels. The case will be heard in Sydney in the Federal Court of Australia at the end of July and Roche believes that further debate and discussion should be left to the court. Roche is taking the action against the Committee through the individual members as it is the only way for us to challenge the NDPSC decision."


So says the brief statement issued by Roche late last week.

AusPharm was alarmed when we first read in Friday's Australian newspaper that Roche were going after the individual members of the NDPSC, some of whom are pharmacists and some of these, AusPharm suspects, are AusPharm members too. Many 'listers will be aware that AusPharm saw the inside of the Federal Court last year so we have some sense of how it feels to have big pharma go after you.

However, as we attempted to find out more during Friday and over the weekend our fears were allayed to some extent. Industry sources who spoke to AusPharm confirmed that the only way to challenge the NDPSC's February decision to revoke the approval for direct to consumer advertising of Xenic*l is to take action against the individual members of the NDPSC in the Federal Court.

There were claims in media reports that the basis for Roche's claim is that the NDPSC incorrectly based its decision on evidence presented by Choice after a 'mystery shop' of 25 Sydney pharmacies.

We were, unfortunately, unable to obtain a copy of Roche's statement of claim against NDPSC members so we are unable to confirm this. Roche declined our request for more information (as the matter is now before the court). AusPharm spoke to one member of the NDPSC who was unaware that he had been 'joined' to the claim! Another member declined a request to speak to us, also because the matter is now before the court.

CHOICE have been invited to appear in the federal Court at a hearing scheduled for late July. They were 'ordered' by the court to submit documents relating to their Xenic*l survey to the Court by June 20.

We spoke to CHOICE and they told us that they had complied with this order. Further, they had no problem with this as their survey methodology was 'robust and transparent'.

AusPharm believes that the NDPSC will defer consideration of this issue at their meeting this week because the matter is now before the courts.

Timeline of events

Oct 03: NDPSC approves Xenic*l for S3 (down-scheduled from S4). This decision was gazetted in Dec 03
May 04: Xenic*l becomes available as a Pharmacist Only Medicine (S3)
Feb 06: NDPSC grants Appendix H status
Jun 06: NDPSC ratifies above decision
Sept 06: Xenic*l consumer advertising commences (significant because Australia becomes one of the first countries in the world to allow direct to consumer advertising for Xenic*l)
Sept 06: Choice submits complaint to TGA
Oct 06: Roche voluntarily takes Xenic*l advertising off air
Oct 06: TGA Complaints Resolution Committee meets to discuss Choice complaint
Oct 06: TGA Complaints Resolution Committee dismisses complaint that Roche was targeting children by advertising in Australian Idol but upholds the complaint that the advertisement was not specific enough and advises that Roche make modifications in line with Xenic*l’s approved indication
Oct 06: NDPSC meets to discuss Choice complaint including calls for Xenic*l to be rescheduled to prescription only and decides to consider at February 2007 meeting
Feb 07: NDPSC announces that Xenic*l should remain a Pharmacist-Only medication but withdraws Appendix H. It recommends the deletion of orlistat from App H - this is to be ratified at the June 26-28 NDPSC meeting

Post a comment to AusPharmList.

 

  

Crikey! Colesworth in the wholesaler equation?

 
Last Fridays' Crikey ran an interesting story suggesting that the entry of private equity into wholesaler ownership might offer Colesworth a way into pharmacy. The reasoning goes like this.

Under the Healthscope/Symbion agreement, the drug businesses, including the pharmacy brands go to private equity, Ironbridge and Archer Capital. But "Private equity is not really interested in running a business in the long term. They like to fatten companies and flog them to the highest bidder, or list them."

Enter Colesworth.......

The full story is here.

Post a comment to AusPharmList.

 

  

AusPharm Research Roundup

 

25/06/2007 :

Clinical update: new treatments for hot flushes

The available data suggests that oestrogen or progestagen, or in combination, is the best therapy for hot flushes, and may alleviate other symptoms associated with the menopausal transition. Centrally acting agents, such as SSRI/SNRI and gabapentin, are associated with a modest reduction in daily hot flushes. Isoflavones might be associated with a small reduction in symptoms. It is recommended that women with mild vasomotor symptoms consider lifestyle modification with or with-out a non-prescription remedy.

Lancet 2007;369:2062-4.
Post a comment to AusPharmList.

Pregabalin (Lyrica) approved for treating fibromyalgia

Pregabalin (Lyrica) has been approved for treating fibromyalgia in the USA. Pregabalin is approved for use in diabetic peripheral neuropathy and postherpetic neuralgia. The expanded approval was based on two double-blind controlled trials involving about 1800 patients. The most common side effects are mild-to-moderate dizziness and sleepiness.

FDA report June 2007
Post a comment to AusPharmList.

Estrogen Therapy and Coronary-Artery Calcification

Among women 50 to 59 years old, the calcified-plaque burden in the coronary arteries after trial completion was lower in women assigned to estrogen than in those assigned to placebo. Calcified coronary artery plaque is highly predictive of future cardiovascular events. This data provides some reassurance that oestrogen is unlikely to have an adverse effect on the risk of coronary events among women who have recently undergone menopause and are considering hormone therapy for the treatment of menopausal symptoms. It shows that women who started oestrogen between the ages of 50 and 59 have significantly less coronary artery calcification than those who took placebo at the same age. It provides support that HRT is only beneficial if started before atherosclerosis is established; but the findings do not indicate that oestrogen should be used to prevent cardiovascular disease.

New Engl J Med 2007;356:2591-2602.
Editorial: http://content.nejm.org/cgi/content/full/356/25/2639
Post a comment to AusPharmList.

Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density

Women who obtained calcium primarily from the diet or from both the diet and supplements had significantly lower ratios of non-oestrogenic to oestrogenic metabolites than did those who obtained calcium primarily from supplements. Adjusted BMD z scores were significantly greater in the subjects who obtained calcium primarily from the diet or from both the diet and supplements than in those who obtained calcium primarily from calcium supplements.

Am J Clin Nutr 2007;85:1428 -1433.
Post a comment to AusPharmList.

Click Here to view the archive


AusPharm Research Roundup is a weekly column collated by Debbie Rigby that is designed to bring AusPharmers a summary of selected research papers published during the preceding week or two.

 

  

AusPharmList posts


  (UK) Parliamentarians don't support Reclassification of Pseudoephedrine
 
 

From: "Bill Arnold" farmacia@bigpond.net.au

http://transform-drugs.blogspot.com/2007/06/ parliamentarians-dont-support.html

Below is copied a press release issued jointly by two all party parliamentary groups (drug misuse and primary care and public health) this week calling for the MRHA not to reclassify over the counter medicines containing ephedrine and pseudo ephedrine as prescription only.

This follows on from the recent kerfuffle about the dangers of cold remedies, such as Lemsip and Sudafed which contain the drugs in question (albeit in relatively tiny doses), being used in the illicit manufacture of meth amphetamine. As discussed here the recent War on Lemsip blog such a move would be largely gesture politics, and have no discernible impact on the production supply and use of meth amphetamine. As we have seen over the past century's experience of trying to prohibit drugs that are in demand, such moves will always fail. If there is profit to be made then illicit markets will always find a way to produce and supply.

 


  Do you use Packman with LOTS?
 
 

From: "John Sobkowiak" aquabuggy@hotmail.com

Can anybody tell me some of the pros and cons of using "Packman" with LOTS?.

 


  FERRO LIQUID CMI?
 
 

From: "Peter Ryan" robinaparkway.mcp@nunet.com.au

Does anybody know why there is no CMI available for Ferro Liquid ? It has been on the PBS for some time now, yet no CMI is available. As far as I am concerned, this is not acceptable.

 


  

Pharmacy Assistant of the Year

 


 

  Re: Online claiming for PBS technical difficulties fixed
 
 

From: "Amanda Galbraith" amandag@capitalchemist.com.au

Just wondering whether the sudden influx of pharmacies trying to go online before June 30 is responsible for some of these issues. Does MA think the system will be able to cope with the volume of scripts processed through PBS online?

Amanda Galbraith
Capital Chemist Chisholm

 


  Ural
 
 

From: "Vicki Dyson" vickidyson@optusnet.com.au

In performing nursing home reviews, I come across Ural being ordered prn on charts and nursing staff giving it to patients tds regularly for years on end.

The residents still get their UTIs from time to time. I have pointed out its potential to raise blood pressure, worsen CCF and reduce some anitbiotic efficacy. Does anyone have any source of evidence that changing pH of urine either up or down alters the frequency of UTIs?

I would like to be able to quote an article which I can use to back up my recommendation to cease regular use?

Vicki Dyson

 


  xeloda
 
 

From: "anderson leong" andersonleong@hotmail.com

Has anyone had problems with Xeloda 500mg 120 tab's from API price $677 ex gst, while Winifred is $662.26?

I asked API but they said that is the price, go and order it direct from Roche.

 


  Re: Secure emails to Doctors
 
 

From: "Andrew Roberts" stuff@bitethedust.com.au

Terry Irvine wrote:

"Yesterday, a doctor told me I should not have sent him an email that was not encrypted. All communications between doctors is now encrypted, he said. How do we become part of this privacy preserving protocol"

----------

I'd say the doc's having a bit of a lend. Many don't know how to use the encryption process. Didn't a Melbourne hospital (Austin?) feature in the news a few months back when a GP went public about emails that weren't encrypted? From memory their privacy committee had looked at this before starting sending emails and decided that the importance of getting the info to the GPs was more important than the risk of an unencrypted email being intercepted. Part of the decision making was looking at how few doctors could use the encryption technology.

Our patient care would be reduced without email.

Robbo

 


  Re: Riddle me this....
 
 

From: "Andrew Roberts" stuff@bitethedust.com.au

Philip Smith wrote:

"I had a young gentleman (under 30) present to the pharmacy with a few areas on his face that have stopped growing hair. The skin looked completely normal and the same as the skin with hair, no redness, sign of infection, nothing. Could it be Alopecia Areata from my google search?"

--------------

Any hair loss on the outer third of the eyebrows or perhaps blisters/rash on the soles of his feet? We see patchy alopecia (not necessarily on top of the head) out here and think secondary syphilis.

Robbo

 


  Re: '01' code to go
 
 

From: "irwin lowe" irwin@heidelbergcentralpharmacy.com.au

Adam Hay wrote:

"A cardholder's entitlement may end for any number of reasons. Andrew Topp rightly noted that these are irrelevant for the purposes of the pharmacist. You are either entitled or not entitled to concessional benefits at a given time.

It is the patient's own responsibility to ensure they are using a valid card.

If you are presented with a card which has an expiry date beyond today's date but PBS online says it is invalid today, that is the end of the matter. It is a general copayment, a S87A receipt and a trip to the Medicare office.

Why would you check the '01' box if PBS online says it is invalid?"

----------

So my father walks into your pharmacy for his BP, cholesterol & CV drugs, after his quadruple bypass. He has a concession card with a long expiry. Lo and behold, PBS online reports that the concession is CANCELLED. You tell him that he is a vicious bastard for rorting the system, and further (assuming he hasn't demanded his rxs back and stormed out) charge him $100 for what should have been $15 worth of scripts.

Here's my dad's email from today:

"More funny is Centrelink. I opened my mail yesterday at 4.30pm, Centrelink wrote that I havnt provided them with current address, therefore my cwlth hlth card was cancelled on 16 June. I dashed to westfield centrlk, running and panting to their office which closes 5.00pm. I told the lady that I have not moved for 25yrs and I received Centrlink letter addressed correctly, what's really happening? The lady suggested that somebody has informed centrlink something, or I have gone overseas without proper notification. I said none of these things haven ever happened and my income now is much lower that last fiscal year which I have already provided with a copy. She reinstated my entitlement right away. I don't know whats going on there, apparently something is happening, I am waiting for their explanation."

OBVIOUSLY, the chemists & the public are rorting the system.

Irwin the evil chemist.

 


  Re: Pearl: Wondermycin tds mnn
 
 

From: "Andrew Roberts" stuff@bitethedust.com.au

Peter Bayly wrote:

"Then I spoke to some prescribers who put i tds ac or pc and their motivation was to improve compliance by taking the drug at meal times.... So my standard advice is to take amoxycillin at meal times to help the patient remember"

----------------

Aren't you better to discuss and adjust the dosing schedule with the individual receiving the medication? Perhaps I have been out bush too long where meals aren’t necessarily a certainty with my mob. They might only take one capsule a day following this recommendation. I tend to use the position of the sun and reinforce the times in their language.

Robbo

 


  

2008 NICS-NPS QUM Fellowship

 


 

  Re: Inappropriate(?) S3 supplies by others.
 
 

From: "Peter Crothers" peter.crothers@stratman.com.au

Peter Bayly wrote:

"A recording system is needed for ALL S3 drugs and some S2 drugs to effectively monitor abuse or inappropriate use...."

----------

I agree. I used to be sceptical about this, but now I'm so convinced, I reckon its a 'no brainer'. If S3 is for medicines that require pharmacist recommendation and/or monitored supply, then it follows like night follows day that supply should be recorded. With scanners etc., this is so easy to do nowadays that it is no imposition at all, especially with a dispensing station nearby to the S3s, which most of us increasingly need anyway, in order to assist script counselling, answer questions from 'regulars' (remember the regulars? the patients that probably account for most of our profitability?), etc.

Across the board S3R would also help patients understand that there is a material difference between S3 and "OTC"; help them understand and appreciate the role of pharmacists; and encourage a 'local service/ regular customer model' of pharmacy practice that would assist the profession in meeting Guild/PSA, government and consumer organisation expectations (have I said something controversial?)

If all S3s required recording, the argument about large packs of Panafen Plus would be simple: whack it in S3. We had a serious local abuse problem with 48 packs of Nurofen+ and Panafen+ (we won't stock the 72s) which we 'solved' overnight by 'voluntarily' making them S3R. So simple. And guess what? The people who aren't deliberate abusers really appreciate that we are interested in their wellbeing. So, it's good for business as well.

What do others think?

Peter C

 


  Re: Contraception
 
 

From: "Bruce Moffat" chemco@optushome.com.au

Philip Smith asked

"Just wondering other pharmacist thoughts, or history on the situation as to why they are not funded, the oral contraceptive pill is this sexist"

----------------------------

Any historically under or unfunded device, medication, or procedure related to control of conception in Oz in the last 15 years probably has a 2 word cause. Brian and Harradine. Fortunately, the burden of carrying the responsibility of forcing his moral perspective on the rest of the country became too much for him and he is now retired.

Upon his unlamented passing the first wave of erosion was RU-486, and also Emergency Hormonal Contraception (going off S4). Hells bells, if this continues apace we may get decent universal sex education instead of flagpoles in all our primary schools.

Cheers,

Bruce

 


  [student] : Re: Privacy
 
 

From: "Ben Wishaw" auspharm@buz81.cjb.net

Peter Bayly wrote:

"....a complaint from a patient that the word Zoloft appeared on the screen at the checkout of her pharmacy and she was upset that those in the queue behind her could also read it."

----------

The pharmacy I work in shows the patient name and the medications. The screens are angled away from the customers. I know that I use the information to check that the patient has the correct items and I have picked up errors a few times at the counter.

I believe that as long as steps are taken to keep this information to the "checkout" staff it can be used effectively to prevent dispensing errors.

 


  Re: Privacy
 
 

From: "Ian Bodycote" jjulihol@bigpond.net.au

Peter Bayly wrote:

"....a complaint from a patient that the word Zoloft appeared on the screen at the checkout of her pharmacy and she was upset that those in the queue behind her could also read it."

----------

To even complicate matters more , it is my understanding that these electronic display poles on registers are compulsory for retailers: if we display we are in breach of privacy if we don't we are in breach of some retailing law: so what is the answer ?

 


  Re: Privacy
 
 

From: "Harriet Wright" gulgongdispensary@bigpond.com

Peter Bayly wrote:

"....a complaint from a patient that the word Zoloft appeared on the screen at the checkout of her pharmacy and she was upset that those in the queue behind her could also read it."

----------

Dear Peter

We have a display which shows product names for OTCs but scripts are displayed as "script". It can also be turned off at customer request and we have a sign stating this fact on the display. We place all script items in a paper bag in the dispensary and store them in that bag until handed to the customer.

Cheers
Harriet Wright
Gulgong Dispensary

 


  Re: Privacy
 
 

From: "Geoff Timbs" warnersbay@amcal.net.au

Peter Bayly wrote:

"....a complaint from a patient that the word Zoloft appeared on the screen at the checkout of her pharmacy and she was upset that those in the queue behind her could also read it."

----------

Perhaps QCPP could come up with a sign near the entrances to advise that pharmacies are a privacy free zone, that you will be videotaped and conversations recorded for training purposes. Those unwilling to partake should feign a husky voice & wear a disguise - perhaps a bin of wigs & dark glasses at the door to assist - traffic flow would probably increase!

I recall when feminine hygiene products were pre-wrapped in brown paper and condoms were sold on veiled request from the 'indoor sports' drawer behind the counter and total strangers did not talk on mobiles about everything just about everywhere- but that just highlights my age rather than any relevance to privacy being relative....we seem to have accepted more intrusion into our everyday lives but believe our illusory privacy is sacred.

Geoff Timbs - Friday night rant.

 


  Re: Medicare Nos. & RMMR
 
 

From: "Penny Kraemer" penny_kraemer@optusnet.com.au

peter howard wrote:

"After completing Medication Reviews in a Nursing Home yesterday, I phoned the Medicare Hotline to check Medicare numbers for some residents (these must now be included on the new RMMR claim forms). I was told by two separate operators and a supervisor at Medicare that they are allowed to give these numbers ONLY to pharmacists who are dispensing a script. Furthermore, I was told that I should only include 6 names on the claim form, and not 8 as indicated, as the forms were printed before Medicare realised that their computer system could only handle 6 names at a time!... What a farcical situation!"

----------

Peter,

I have emailed Glenys Fitzpatrick at the Medicare Incentives Department in SA twice this month regarding the same issue as you described. On both occasions she told me that she had referred the query to National Office and that either she or they would get back to me.

Still waiting.....

Interesting re the number of reviews on the form, didn't know that one!!!

The alternative at the moment is to get the number from the pharmacy who is supplying the medications to the facility.

Penny Kraemer

 


  Re: Medicare Nos. & RMMR
 
 

From: "Damien Louttit" louttit@dodo.com.au

peter howard wrote:

"After completing Medication Reviews in a Nursing Home yesterday, I phoned the Medicare Hotline to check Medicare numbers for some residents (these must now be included on the new RMMR claim forms). I was told by two separate operators and a supervisor at Medicare that they are allowed to give these numbers ONLY to pharmacists who are dispensing a script. Furthermore, I was told that I should only include 6 names on the claim form, and not 8 as indicated, as the forms were printed before Medicare realised that their computer system could only handle 6 names at a time!... What a farcical situation!"

----------

Welcome to a day in the life of a Community pharmacist !!

Damien Louttit
Community Pharmacist
Sth Coast NSW

 


  Re: Medicare Nos. & RMMR
 
 

From: "Edgar SMALL" edgarsmall@bigpond.com

peter howard wrote:

"After completing Medication Reviews in a Nursing Home yesterday, I phoned the Medicare Hotline to check Medicare numbers for some residents (these must now be included on the new RMMR claim forms). I was told by two separate operators and a supervisor at Medicare that they are allowed to give these numbers ONLY to pharmacists who are dispensing a script. Furthermore, I was told that I should only include 6 names on the claim form, and not 8 as indicated, as the forms were printed before Medicare realised that their computer system could only handle 6 names at a time!... What a farcical situation!"

----------

Surely the Pharmacy where these patients had their prescriptions dispensed would have their medicare numbers on file. Apart from having to make another phone call I don't see where there is a problem!!

Edgar Small
Community Pharmacist
WINDSOR NSW

 


  Re: Streamlined authorities
 
 

From: "Geoff Timbs" warnersbay@amcal.net.au

Andrew Topp wrote:

"Does anyone know if there will be any extra processing requirements for pharmacists using the streamlined authority system? Or is the whole process in the prescriber's domain?"

----------

Curiously no one has bothered to tell us so I called MA: at first I was told all changes were embargoed until 7 days before the change but eventually I was put onto a pharmacist whistle-blower (name withheld in case ASIO is reading this).

I was told.....streamlined authorities will be in the same format as phone authorities except instead of the "Z" approval No the Dr will now enter the 4 digit code supplied in the PBS shedule but more likely from the software. Pharmacist checks is 4 digits, not 3, not 5, no letters, etc and processes as previously for a phone approval. We do not have to check the 4 digits match the code in the shedule (...yet, but I imagine MA will make us responsible so they can have the usual run of trivial rejections). So essentially it is like the old days when we had to check the DR wrote "SP" specified purpose on some scripts ( but naturally more complicated).. the more things change....

Geoff Timbs B.Pharm

 


  Re: 200 scripts a day then get another pharmacist
 
 

From: "Peter Bayly" pdlsa@bigpond.com

Christopher Morris wrote:

"I know some pharmacists who would make mistakes doing 10 scripts a day. Meanwhile i regularly do 300+ in a day and haven't made a mistake for years. I honestly can't see how any form of regulation is feasible whatsoever."

----------

How do you know you haven't made a mistake? And at 300 a day your first mistake is to leave inadequate time to add professional services to the supply function.

With that in mind, there obviously IS a need for regulation and it IS possible to factor in those variables.

 


  Re: 200 scripts a day then get another pharmacist
 
 

From: "Ron Batagol" rbatagol@optusnet.com.au

Christopher Morris wrote:

"I know some pharmacists who would make mistakes doing 10 scripts a day. Meanwhile i regularly do 300+ in a day and haven't made a mistake for years." (my italics and bold print)

------------------------

Oh, my G*d, Christopher! It seems that you have found the dispensing "Holy Grail! And, it appears that I've got it wrong, when, after all these years of supervising large numbers of pharmacists and pharmacy interns, on a daily basis, I routinely give them the advice that "the pharmacist who says that they have never made a mistake in dispensing a script is either a liar or is just kidding themselves"!

Let me just remind Christopher and others who say that they can dispense 300 scripts a day, (faultlessly or otherwise) that there are certain defined steps in the dispensing process, that a pharmacist, and ONLY A PHARMACIST, must carry out for each and every script, including repeats! These steps are, of course, "set in stone", as absolute, not discretionary, requirements, not just by Pharmacy Boards, (whose Guidelines, after all, simply reflect the accepted prevailing professional standards), but by our professional organisations themselves, which developed those standards, as well as by professional indemnity insurers. Indeed, it is a pharmacist, and only a pharmacist, who is obliged to "sign off" on interpreting the prescriber's intentions and contact where appropriate, review of the medication history, (including special requirements and considerations such a pregnancy, breast-feeding paediatric doses/ dose form/calibrated measures), checking of potential script interactions, and, of course, as specified in all of the above professional and Board standards, counselling of each and every script including repeats,( and as you've all heard before, for repeats, the need to ensure that what you are dispensing reflects the latest medication regimen- remember my recent article, "no squirrelling"). Now, for repeats, of course, the end-point patient counselling may be as simple as- "how are this med going- any problems, any new med issues- herbals or other self-meds" etc.etc.etc.) - Ok it doesn't take long for repeats, but it has to be done! But, of course, for new meds, counselling must include emphasising instructions and highlighting the key points of a CMI .

Of course, I admit that there are existing and potential smart and innovative ways of streamlining the dispensing processes. For instance, optimal use of technicians/trained pharmacy assistants, And I, for one, have expressed openly, that, in this day and age when we have scanners and hopefully, smarter work station arrangements, I have no problem with one pharmacist supervising more than the current statutory, one only, trained technician/pharmacy assistant, to make the dispensing process more efficient (since this can already occur legally for the far more complex and error-prone operations of dose administration packing/dispensing.) We all hope that this legal change may come about sometimes soon!.

And, as we've read, there's the emerging robotics option. However, on that score, as noted during the current is discussion by Peter Bayly, on the topic of the consideration of dispensing robots..."the machine referred to saves a few seconds in product selection which is still subjects errors in keying, interpretation etc. It was described by one writer as a piece of theatre displayed in a shop window to attract extra prescriptions and produce a peak of 161 prescriptions in an hour. This then is counter-productive in allow ing more time for counselling unless 4 pharmacists are on hand to deliver professional services."

And, at the end of the day, that's the critical point, isn't it - As I pointed out above, a pharmacist and only a pharmacist, can "sign off" on the professional aspects of a script, and a pharmacist, and only a pharmacist must, and should, by agreed legal and professional standards, counsel each and every patient receiving their scripts.

So, in the end, it's quite simple really and boils down to the question that I would ask Christopher -, namely": Are you really saying that you can do all of these things at the rate of 300 scripts a day, and as a special bonus, never make a mistake! Well, if so, you are not only a very fast, and super-gold- standard dispensing pharmacist, but also, to fit all that mandatory patient counselling in as well- hey, you must be a very fast talker.!"

But, for the rest of us lesser mere mortal souls, for the sake of industry uniformity, and most importantly of all, guaranteed patient safety, as a majority of AusPharmListers have agreed in the most recent poll, we desperately need, at least an accepted professional and statutory guideline, to the safe upper limit of our basic dispensing operations, in line with basic operational standards in just about every other industry and profession!

Ron Batagol

p.s. When Christopher says" I regularly do 300+ in a day and haven't made a mistake for years" I would suggest that what he is really saying is "I'm not aware of any mistake that I have made in that time" And - there is a difference!

 


  Re: PBS online rejection codes
 
 

From: "Ian Bodycote" jjulihol@bigpond.net.au

Suhail Mir Mohamed wrote:

"Anyone else finding the old system a lot easier to reconcile? This is just far too complicated? Perhaps with all the money saved with PBS online, these might be room in the budget for having someone come out and explain to us how to reconcile our statements properly."

----------

Well we are dealing with multiple part payment of claims in one hit with PBS online: personally I find the time lag receiving payment advices frustrating but the worst aspect is that you never actually know what amount you will receive on payment day

 


 

AusPharm news links

 
 Assets play proves a bitter pill for Sigma as Symbion board swallows rival bid
The Age 25/6/2007
Sigma Pharmaceuticals has all but conceded defeat in its $1.1 billion fight for rival Symbion's pharmacy and consumer assets.   More...
 Naltrexone trial proposed in ACT
ABC news 24/6/2007
Key drug advisory groups and specialists will meet in Canberra today to discuss the idea of an ACT trial for the methadone substitute drug naltrexone.   More...
 Hirst cabinet sets auction record
BBC news 24/6/2007
One of Damien Hirst's trademark medicine cabinets has sold at auction for £9.65m, breaking the European record for work by a living artist.   More...
 It's a brand new game
The Age 24/6/2007
HAS your favourite jar of pickles or packet of kitty litter suddenly disappeared from the supermarket shelf? Get used to it — it's merely the beginning of a major roll-out of "house" brands that will see many low-selling items taken off the shelves to make room for the new ranges.   More...
 Prescription drugs to be new road toll aim
The Age 24/6/2007
PRESCRIPTION drugs are the new target in the war on the road toll. Senior traffic police and road trauma experts want booze buses testing for Valium as well as vodka, benzodiazepines as well as beer.   More...
 Chemist scheme rewarded for drug fight
The Australian 23/6/2007
AN online database that prevents "pseudo runners" from buying up dozens of packets of cold and flu medicine for manufacture into illegal drugs has won a national award.   More...
 Scheme praised over pseudo runners halt
The Age 23/6/2007
An online database that prevents "pseudo runners" from buying up dozens of packets of cold and flu medicine for manufacture into illegal drugs has won a national award.   More...
 Diabetes drug fails to shake fears
The Australian 23/6/2007
WHEN he first saw the results of his study about the cardiovascular risks of the diabetes drug rosiglitazone - sold under the trade name Avandia - several weeks ago, Steven Nissen said that he felt sick and was unable to sleep.   More...
 Warning on drugs to cut post-surgical heart attacks
The Australian 23/6/2007
DOCTORS are routinely giving drugs to patients in the belief they reduce post-surgical heart attacks when there is little or no evidence that they do any good - and in fact can cause significant harm.   More...
 $4m shot in the arm for alternatives
The Australian 23/6/2007
ONE of the biggest discrepancies in modern healthcare - that herbal and other alternative treatments have little of the formal scientific evidence demanded of prescription drugs - will be tackled after the federal Government announced a $4 million grant to establish a new National Institute for Complementary Medicine.   More...
 Pharmacists prescribe a dose of relaxation
Bay Post 22/6/2007
RETIREMENT is the best medicine for Moruya's long-serving pharmacists, Amanda and Michael Ryan.   More...
 'Insulin pill' hope for diabetes
BBC news 23/6/2007
Diabetes patients may soon be able to take a pill to control their condition instead of repeated injections. UK company Diabetology, with experts at Cardiff University, says it has solved a crucial problem with oral insulin.   More...
 How to deal with the angry customer
The Age 22/6/2007
So how do we handle the angry customer? BusinessWeek has come up with seven answers:   More...
 New European Guidelines on Treatment of Hypertension
Medscape 22/6/2007
New guidelines for the management of arterial hypertension have been issued at the European Society of Hypertension (ESH) meeting in Milan, Italy. The recommendations, which were drawn up jointly by task forces from ESH and the European Society of Cardiology, also appear in the Journal of Hypertension.   More...
 Doctors change mind on HRT
The Age 22/6/2007
Doctors now say hormone replacement drugs can lower the chance of heart disease.   More...
 ASA supports Symbion's decision on Sigma's late bid
The Age 22/6/2007
The Australian Shareholders Association throws its support behind Symbion's decision to dismiss a higher but late bid from Sigma Pharmaceuticals.   More...
 Natural insulin hopes
Herald Sun 22/6/2007
SCIENTISTS say a treatment for one of the world's most prevalent diseases may have been found growing on trees.   More...
 

 

The last word

 
 FDA approves 'Computerised Medication Box' for U.S. Market
National electronic Library for Medicines 23/6/2007
The U.S. Food and Drug Administration has cleared for marketing the INRange Systems' Electronic Medication Management Assistant (EMMA). This is a programmable device that stores and dispenses prescription medication for patients' use in the home. EMMA consists of a medication delivery unit and two-way communication software that allows a health care professional to remotely manage prescriptions stored and released by the patient-operated delivery unit. The delivery unit is about the size of a bread box.   More...
 Postmenopausal Hormone Therapy and Coronary Disease
Newswise 22/6/2007
The results of WHI-CACS, now published in N Engl J Med, re-affirm that estrogen has a wide range of well-documented beneficial metabolic and vascular effects, provided that treatment is started early in the menopause. Women can be reassured that estrogen therapy is cardioprotective at least until age 65.   More...
 

 About AusPharm(e)news
 
 AusPharm(e)news is a daily ezine published by AusPharm.net.au P/L incorporating:
  • posts to the AusPharmList discussion forum
  • industry news
  • links to pharmacy relevant pieces in the mainstream media
  • AusPharm Practice pearls
  • AusPharm feature articles
AusPharm(e)news is published each week day and is emailed to subscribers each morning, usually between 7AM and 8AM.

AusPharm.net.au P/L is a company owned by Tasmanian pharmacists Mark Dunn and Tony Wiss.

 

  AusPharm supporters
 
 AusPharm gratefully acknowledges the support of the following organisations in enabling the production of the AusPharm suite of websites and AusPharm(e)news.
  
 Priceline Pharmacy  The Pharmaceutical Society of Australia
 The Pharmacy Guild of Australia  nuNET broadband Internet for pharmacists
 Sandoz  Roche Diagnostics
 The Australian Association of Consultant Pharmacy  Raven's Pharmacy Services
 Johnson & Johnson  Webstercare
 Pfizer Australia  practice4sale
 jobs4Careers  Pharmaceutical Defense Ltd
 Johnston Rorke  Professional Compounding Chemists of Australia
 Allied Health Employment
 The Australian Pharmaceutical Publishing Company (APPCo)
 The Australian College of Pharmacy Practice and Management
  

 

 Contact AusPharm
 
 General enquiries: info@auspharm.net.au
    
 Technical & websites: Caine Barlow > caine@auspharm.net.au
    
 Editorial: Mark Dunn > mark@auspharm.net.au
    
 Advertising: Mark Dunn > mark@auspharm.net.au
    
 AusPharmList: Mark Dunn > mark@auspharmlist.net.au
    
 AusPharmacist.net.au page: Tony Wiss > tony@auspharm.net.au
    
    
 All other enquiries:  Mark Dunn > mark@auspharm.net.au
or by phone 61 3 6239 6102 or 0427 981517

    Tony Wiss > tony@auspharm.net.au

    Our fax number is: 61 3 6239 6102

 

 Frequently asked questions
 
 

How to post to AusPharmList

Posting a new thread.

  • Post by email --> Send your post by email to auspharmlist@auspharmlist.net.au
  • Post online --> At the AusPharmList website click on the "Start new thread' Link and follow the prompts. Please note that your post won't immediately appear online as it needs to be reviewed by the moderator first.
  • From AusPharm(e)news using the online method --> Click on the button and follow the prompts. Please note that your post won't immediately appear online as it needs to be reviewed by the moderator first.
  • From AusPharm(e)news by email --> Click on the button and then compose and send your post.

Replying to an existing thread

  • From AusPharm(e)news by email --> Click on the button . We are aware that there is an error here for some people and while this button will work most of the time for most people, it will occasionally fail
  • From AusPharm(e)news using the online option --> Click on the button and follow the prompts. Please note that your post won't immediately appear online as it needs to be reviewed by the moderator first.
  • From the AusPharmList website --> when viewing a post online at the AusPharmList website, there is a link with each post to "Reply to this post" --> Click on this link and follow the prompts. Please note that your post won't immediately appear online as it needs to be reviewed by the moderator first.

Issues with receiving and reading AusPharm(e)news

Most (but not all) people using the following email applications report that they can read AusPharm(e)news without difficulty.

  • Outlook Express
  • Outlook
  • Eudora
  • Hotmail
  • Yahoo Mail
  • Thunderbird
  • Netscape Mail

There are however some issues that we know about for some people.

Some versions of Norton anti virus/spam software recognise the (e)news as spam and put it in the spam folder for some people. For some of these people it doesn't seem possible to tell Norton that the (e)news isn't spam and have it appear in your email inbox. There do not appear to be issues with spam filters other than other than this one. On some days, however, keywords displayed in the subject line of the day's (e)news may trigger all spam filters to see the (e)news as spam (eg V***ra)

Some people have reported that they were getting the text but not the images in the (e)news. This was resolved for most of these people by changing a setting in the email program options. For example, in Outlook Express: go to Tools --> Options --> Security and UNcheck the box that says "Block images and other external content in html email". Most email applications will have a similar option to turn on or off, as the case may be.

There seem to be a few issues that are unique to particular workplaces (and specific mail servers), with a couple of organisations reporting that members are not receiving the (e)news at all. One organisation is receiving it but their members' email application (Outlook) refuses to recognise the incoming (e)news as a web page, rendering it unreadable.

Different email clients seem to handle the enews in different ways. Some people receive it as a "inline" formatted email (ie it appears in the body of the email) while for others it appears as an attachment that must be clicked on to open. It may be possible to change this by changing the settings within the individual email application in question.

It is also clear that people are having issues that appear to be unique to them and we would be pleased to work with these people individually to resolve their problems. After reviewing the information above, and seeking assistance locally where available, please send a detailed description of your issue by email to mark@auspharm.net.au and we will see if we can help.

Each day AusPharm(e)news comes with a text only link to the online version. If all else fails, people having difficulty reading the (e)news should be able to read it without difficulty at the online location. There is a link to each day's online (e)news from the main AusPharm web page @ www.auspharm.net.au